Compounds and methods for modulating desmosomal cadherin-mediated functions
CA 2404202 A1 · Owner: Adherex Technologies, Inc. · Inventors: Gour, Barbara J.; Blaschuk, Orest W.; Symonds, James Matthew
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Modulating agents for inhibiting or enhancing desmosomal cadherin mediated cell adhesion are provided. The modulating agents comprise one or more of: a) a peptide sequence that is at least 50% identical to a desmosomal cadherin CAR sequence; b) a non-peptide mimetic of a desmosomal cadherin CAR sequence; c) a substance, such as an antibody or antigen-binding fragment thereof that , specifically binds a desmosomal cadherin CAR sequence; and/or d) a polynucleotide encoding a polypeptide that comprises a desmosomal cadherin CAR sequence or analogue thereof. Methods for using such modulating agents for modulating desmosomal cadherin-mediated cell adhesion in a variety of contexts are …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.